OppenheimerFunds’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $3.09M | Buy |
38,329
+4,593
| +14% | +$370K | ﹤0.01% | 814 |
|
|
2018
Q4 | $3.11M | Buy |
33,736
+2,457
| +8% | +$227K | ﹤0.01% | 799 |
|
|
2018
Q3 | $2.96M | Sell |
31,279
-246,320
| -89% | -$23.3M | ﹤0.01% | 842 |
|
|
2018
Q2 | $25.7M | Sell |
277,599
-111,896
| -29% | -$10.4M | 0.03% | 519 |
|
|
2018
Q1 | $36.9M | Sell |
389,495
-21,974
| -5% | -$2.08M | 0.05% | 397 |
|
|
2017
Q4 | $39.8M | Sell |
411,469
-133,655
| -25% | -$12.9M | 0.05% | 375 |
|
|
2017
Q3 | $48.4M | Sell |
545,124
-57,108
| -9% | -$5.07M | 0.06% | 310 |
|
|
2017
Q2 | $43.7M | Sell |
602,232
-130,091
| -18% | -$9.43M | 0.05% | 335 |
|
|
2017
Q1 | $47.7M | Sell |
732,323
-290,723
| -28% | -$18.9M | 0.06% | 317 |
|
|
2016
Q4 | $64.1M | Sell |
1,023,046
-22,145
| -2% | -$1.39M | 0.08% | 258 |
|
|
2016
Q3 | $65.9M | Buy |
1,045,191
+57,944
| +6% | +$3.65M | 0.08% | 269 |
|
|
2016
Q2 | $61.1M | Buy |
987,247
+82
| +0% | +$5.08K | 0.08% | 275 |
|
|
2016
Q1 | $56.4M | Buy |
987,165
+186,261
| +23% | +$10.6M | 0.07% | 276 |
|
|
2015
Q4 | $47.5M | Buy |
800,904
+214,664
| +37% | +$12.7M | 0.06% | 349 |
|
|
2015
Q3 | $31.9M | Buy |
586,240
+19,915
| +4% | +$1.08M | 0.04% | 429 |
|
|
2015
Q2 | $38.1M | Sell |
566,325
-466,025
| -45% | -$31.3M | 0.04% | 414 |
|
|
2015
Q1 | $60.4M | Sell |
1,032,350
-4,247,271
| -80% | -$249M | 0.07% | 330 |
|
|
2014
Q4 | $345M | Buy |
5,279,621
+66,913
| +1% | +$4.38M | 0.38% | 64 |
|
|
2014
Q3 | $301M | Sell |
5,212,708
-138,518
| -3% | -$8M | 0.33% | 76 |
|
|
2014
Q2 | $302M | Buy |
5,351,226
+607,026
| +13% | +$34.3M | 0.33% | 76 |
|
|
2014
Q1 | $244M | Sell |
4,744,200
-39,502
| -0.8% | -$2.03M | 0.29% | 94 |
|
|
2013
Q4 | $253M | Buy |
4,783,702
+1,491,019
| +45% | +$78.7M | 0.31% | 85 |
|
|
2013
Q3 | $147M | Sell |
3,292,683
-337,302
| -9% | -$15.1M | 0.2% | 132 |
|
|
2013
Q2 | $150M | Buy |
+3,629,985
| New | +$150M | 0.22% | 123 |
|